• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部晚期未切除子宫平滑肌肉瘤的放化疗联合热疗三联疗法:一例报告

Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.

作者信息

Shirafuji Aya, Shinagawa Akiko, Kurokawa Tetsuji, Yoshida Yoshio

机构信息

Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan ; Department of Obstetrics and Gynecology, Fukui Aiiku Hospital, Fukui, Japan.

Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.

出版信息

Oncol Lett. 2014 Aug;8(2):637-641. doi: 10.3892/ol.2014.2193. Epub 2014 May 28.

DOI:10.3892/ol.2014.2193
PMID:25009648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4081420/
Abstract

Advanced uterine leiomyosarcoma (LMS) is a rare and extremely aggressive disease. In patients with advanced and unresected uterine LMS, multidisciplinary therapy is the best treatment option, although no consensus exists on the efficacy of the treatment. The present study describes the case of a 41-year-old female who underwent laparotomy due to a large uterine tumor. Exploratory laparotomy revealed a large tumor that had extended from the pelvic wall to the outside of the pelvis and then invaded the colon. Large residual tumors remained present in the pelvis following suboptimal debulking surgery. Subsequent to surgery, the patient was treated with adjuvant radiotherapy, followed by chemotherapy with regional whole pelvis hyperthermia (HT). Computed tomography revealed stable disease prior and subsequent to combination treatment. While treatment was being administered for third/fourth-degree burns and subcutaneous fatty necrosis, the patient developed multi-organ failure and succumbed. The present case report describes the potential for using a combination of chemotherapy, HT and radiotherapy in patients with LMS. The development of an effective protocol is required for the administration of chemotherapy, HT and radiotherapy in patients with advanced unresected LMS.

摘要

晚期子宫平滑肌肉瘤(LMS)是一种罕见且极具侵袭性的疾病。对于晚期且未切除的子宫LMS患者,多学科治疗是最佳治疗选择,尽管对于该治疗的疗效尚无共识。本研究描述了一名41岁女性因巨大子宫肿瘤接受剖腹手术的病例。剖腹探查发现一个巨大肿瘤,已从盆腔壁延伸至盆腔外并侵犯了结肠。在进行了不太理想的肿瘤减灭手术后,盆腔内仍残留大量肿瘤。手术后,患者接受了辅助放疗,随后进行了联合区域全盆腔热疗(HT)的化疗。计算机断层扫描显示联合治疗前后病情稳定。在治疗三度/四度烧伤和皮下脂肪坏死期间,患者出现多器官功能衰竭并死亡。本病例报告描述了在LMS患者中联合使用化疗、HT和放疗的可能性。对于晚期未切除LMS患者,需要制定有效的化疗、HT和放疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/4081420/87e8e4600375/OL-08-02-0637-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/4081420/125fbaf6fad5/OL-08-02-0637-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/4081420/87e8e4600375/OL-08-02-0637-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/4081420/125fbaf6fad5/OL-08-02-0637-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/35b7/4081420/87e8e4600375/OL-08-02-0637-g01.jpg

相似文献

1
Locally-advanced unresected uterine leiomyosarcoma with triple-modality treatment combining radiotherapy, chemotherapy and hyperthermia: A case report.局部晚期未切除子宫平滑肌肉瘤的放化疗联合热疗三联疗法:一例报告
Oncol Lett. 2014 Aug;8(2):637-641. doi: 10.3892/ol.2014.2193. Epub 2014 May 28.
2
Unusual cardiac metastasis of uterine leiomyosarcoma: case report and literature review.子宫平滑肌肉瘤罕见的心脏转移:病例报告及文献复习
Tumori. 2016 Nov 11;102(Suppl. 2):766D193F-C36D-401A-8CF1-D09F9F47B4A4. doi: 10.5301/tj.5000498.
3
Pelvic radiation improves local control after hysterectomy for uterine leiomyosarcoma: a 20-year experience.盆腔放疗可改善子宫平滑肌肉瘤子宫切除术后的局部控制:20年经验
Int J Gynecol Cancer. 2009 Aug;19(6):1080-4. doi: 10.1111/IGC.0b013e3181acae50.
4
Leiomyosarcoma of the sigmoid colon with multiple liver metastases and gastric cancer: a case report.乙状结肠平滑肌肉瘤伴多发肝转移及胃癌 1 例报告
BMC Gastroenterol. 2012 Jul 31;12:98. doi: 10.1186/1471-230X-12-98.
5
Trends in the treatment of uterine leiomyosarcoma in the Medicare population.医疗保险人群中子宫平滑肌肉瘤的治疗趋势。
Int J Gynecol Cancer. 2015 Mar;25(3):453-8. doi: 10.1097/IGC.0000000000000372.
6
[Metastatic lung tumor from uterine leiomyosarcoma].[子宫平滑肌肉瘤肺转移瘤]
Kyobu Geka. 2006 Dec;59(13):1191-6.
7
Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.区域热疗联合放疗治疗子宫颈癌:国际原子能机构的多机构前瞻性随机试验
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):145-53. doi: 10.1016/j.ijrobp.2004.04.057.
8
Options for Adjuvant Therapy for Uterine Leiomyosarcoma.子宫平滑肌肉瘤的辅助治疗选择。
Curr Treat Options Oncol. 2018 Feb 8;19(2):7. doi: 10.1007/s11864-018-0526-0.
9
Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.术前超分割放化疗用于既往盆腔放疗后的局部复发性直肠癌患者:一项多中心II期研究。
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.
10
Leiomyosarcoma of the cervix.宫颈平滑肌肉瘤
Gynecol Oncol. 2003 Dec;91(3):636-42. doi: 10.1016/j.ygyno.2003.08.037.

本文引用的文献

1
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.初次诊断时转移性子宫平滑肌肉瘤患者的手术细胞减灭术。
Gynecol Oncol. 2012 May;125(2):409-13. doi: 10.1016/j.ygyno.2012.02.014. Epub 2012 Feb 21.
2
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.手术中肿瘤碎化对明显早期子宫平滑肌肉瘤患者预后的影响。
Gynecol Oncol. 2011 Aug;122(2):255-9. doi: 10.1016/j.ygyno.2011.04.021. Epub 2011 May 12.
3
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.
固定剂量率吉西他滨联合多西他赛作为转移性子宫平滑肌肉瘤的二线治疗:妇科肿瘤学组II期研究
Gynecol Oncol. 2008 Jun;109(3):323-8. doi: 10.1016/j.ygyno.2008.02.024. Epub 2008 Apr 18.
4
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).评估辅助盆腔放疗在治疗Ⅰ期和Ⅱ期子宫肉瘤中作用的Ⅲ期随机研究:一项欧洲癌症研究与治疗组织妇科癌症研究组研究(方案55874)
Eur J Cancer. 2008 Apr;44(6):808-18. doi: 10.1016/j.ejca.2008.01.019. Epub 2008 Apr 2.
5
Phase II trial of dacarbazine, mitomycin, doxorubicin, and cisplatin with sargramostim in uterine leiomyosarcoma: a Gynecologic Oncology Group study.
Gynecol Oncol. 2005 Nov;99(2):339-42. doi: 10.1016/j.ygyno.2005.06.002. Epub 2005 Jul 26.
6
First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.放疗、化疗和热疗联合的三联疗法治疗IIB期、III期和IVA期宫颈癌患者的初步结果。
Cancer. 2005 Aug 15;104(4):763-70. doi: 10.1002/cncr.21128.
7
Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.埃博霉素743在化疗难治性进展期软组织肉瘤患者中的II期及药代动力学研究。
J Clin Oncol. 2004 Apr 15;22(8):1480-90. doi: 10.1200/JCO.2004.02.098.
8
Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia.中度热疗对新型化疗药物的热增强作用。
Ann Surg Oncol. 2003 May;10(4):463-8. doi: 10.1245/aso.2003.08.006.
9
Evaluation of paclitaxel in previously treated leiomyosarcoma of the uterus: a gynecologic oncology group study.
Gynecol Oncol. 2003 Apr;89(1):48-51. doi: 10.1016/s0090-8258(02)00136-1.
10
Phase II trial of gemcitabine in advanced sarcomas.吉西他滨用于晚期肉瘤的II期试验。
Cancer. 2002 Jun 15;94(12):3225-9. doi: 10.1002/cncr.10602.